Physical and psychosocial aspects of adolescent and young adults after allogeneic hematopoietic stem-cell transplantation: results from a prospective multicenter trial

被引:13
|
作者
Pulewka, Kristin [1 ,8 ]
Wolff, Daniel [2 ]
Herzberg, Philipp Y. [3 ]
Greinix, Hildegard [4 ]
Heussner, Pia [5 ]
Mumm, Friederike H. A. [5 ]
von Harsdorf, Stephanie [6 ]
Rieger, Kathrin [7 ]
Hemmati, Philipp [7 ]
Hochhaus, Andreas [8 ]
Hilgendorf, Inken [8 ]
机构
[1] Univ Hosp Jena, Inst Psychosocial Med & Psychotherapy, Jena, Germany
[2] Univ Hosp Regensburg, Dept Internal Med 3, Regensburg, Germany
[3] Helmut Schmidt Univ, Fed Armed Forces Hamburg, Personal Psychol & Psychol Assessment, Fac Humanities & Social Sci, Hamburg, Germany
[4] Med Univ Graz, Div Hematol, Dept Internal Med 1, Graz, Austria
[5] Ludwig Maximilians Univ Munchen, Dept Internal Med 3, Psychooncol, Klinikum Grosshadern, Munich, Germany
[6] Univ Ulm, Dept Internal Med 3, Ulm, Germany
[7] Charite, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany
[8] Univ Klinikum Jena, Klin Innere Med 2, Abt Hamatol & Internist Onkol, Klinikum 1, D-07740 Jena, Germany
关键词
Adolescents and young adults (AYA); Stem-cell transplantation; Quality of life; Psycho-oncology; QUALITY-OF-LIFE; HUMAN ACTIVITY PROFILE; TERM-FOLLOW-UP; CANCER SURVIVORS; MARROW-TRANSPLANTATION; CARE; VALIDATION; DISTRESS; SUPPORT; INTERVENTIONS;
D O I
10.1007/s00432-017-2424-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Allogeneic hematopoietic stem-cell transplantation (alloHSCT) is physically and psychosocially demanding. Among transplant recipients, adolescent and young adults (AYA) represent a special group, as disease occurs early in life, resulting in the prospect of long survival time and high burden of alloHSCT sequelae. However, data focusing on AYA undergoing alloHSCT are rare. Methods Data resulting from a prospective multicenter trial initially focusing on graft-versus-host disease (GvHD) after alloHSCT were reused to analyse the differences between AYA and elderly patients. In total, data of 205 alloHSCT recipients were evaluated. Patients completed the FACTBMT, HAP, SF-36, 24-AM, LOT-R, BSSS, HADS, and GvHD questionnaires. Results Median age of AYA and non-AYA patients was 29 and 52 years. Using 24-AM-Test, evaluating personality traits, non-AYA reported to be more conscientious (p = 0.033). However, AYA described higher quality of life regarding physical role functioning (p = 0.001), physical functioning (p = 0.002), bodily pain (p = 0.023), and emotional role function (p = 0.027) in the SF-36. General health perception, vitality, social role functioning, and mental health were comparable among both groups. On HAP scale, AYA reported higher maximum (p = 0.003) and adjusted activity scores (p = 0.002), but showed similar restrictions regarding activity, self-supply, and self-determination. Conclusion AYA represent a particular group characterized by higher physical well-being and activity scores, and significantly vary from non-AYA patients in psychosocial aspects. Studies covering distinctive features of AYA undergoing alloHSCT are warranted to improve awareness of the special needs of this group.
引用
收藏
页码:1613 / 1619
页数:7
相关论文
共 50 条
  • [31] Impact of acute kidney injury on overall survival in children and young adults undergoing allogeneic hematopoietic stem cell transplantation
    Matsuoka, Daisuke
    Hirabayashi, Koichi
    Murase, Tsubasa
    Saito, Shoji
    Nakazawa, Yozo
    PEDIATRIC BLOOD & CANCER, 2021, 68 (09)
  • [32] Effect of titrated parenteral nutrition on body composition after allogeneic hematopoietic stem cell transplantation in children: a double-blind, randomized, multicenter trial
    Sharma, Tanvi S.
    Bechard, Lori J.
    Feldman, Henry A.
    Venick, Robert
    Gura, Kathleen
    Gordon, Catherine M.
    Sonis, Andrew
    Guinan, Eva C.
    Duggan, Christopher
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2012, 95 (02) : 342 - 351
  • [33] Outcome of invasive mechanical ventilation after pediatric allogeneic hematopoietic SCT: results from a prospective, multicenter registry
    van Gestel, J. P. J.
    Bierings, M. B.
    Dauger, S.
    Dalle, J-H
    Pavlicek, P.
    Sedlacek, P.
    Monteiro, L. M.
    Lankester, A.
    Bollen, C. W.
    BONE MARROW TRANSPLANTATION, 2014, 49 (10) : 1287 - 1292
  • [34] Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia
    Lee, Catherine J.
    Kim, Soyoung
    Tecca, Heather R.
    Bo-Subait, Stephanie
    Phelan, Rachel
    Brazauskas, Ruta
    Buchbinder, David
    Hamilton, Betty K.
    Battiwalla, Minoo
    Majhail, Navneet S.
    Lazarus, Hillard M.
    Shaw, Peter J.
    Marks, David, I
    Litzow, Mark R.
    Chhabra, Saurabh
    Inamoto, Yoshihiro
    DeFilipp, Zachariah
    Hildebrandt, Gerhard C.
    Olsson, Richard F.
    Kasow, Kimberly A.
    Liesveld, Jane L.
    Rotz, Seth J.
    Badawy, Sherif M.
    Bhatt, Neel S.
    Yared, Jean A.
    Page, Kristin M.
    Arellano, Martha L.
    Kent, Michael
    Farhadfar, Nosha
    Seo, Sachiko
    Hematti, Peiman
    Freytes, Cesar O.
    Rovo, Alicia
    Ganguly, Siddhartha
    Nathan, Sunita
    Burns, Linda
    Shaw, Bronwen E.
    Muffly, Lori S.
    BLOOD ADVANCES, 2020, 4 (06) : 983 - 992
  • [35] Day+100 Platelet Count Predicts Survival After Allogeneic Hematopoietic Stem-Cell Transplantation in Children With Hematologic Malignancies
    Moneib, Hisham
    Hafez, Hanafy
    Abdalla, Amr
    Hassanain, Omneya
    Lehmann, Leslie
    el Haddad, Alaa
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (05) : E221 - E227
  • [36] Impact of a mental training program for pediatric cancer patients after allogeneic hematopoietic stem cell transplantation or high-dose chemotherapy - Results of a randomized controlled trial
    Doering, Michaela
    Xemaire, Johanna
    Werle, Dustin
    Thiel, Stefanie
    Schneider, Veronika
    Michaelis, Sebastian
    Schloesser, Manuel
    Lang, Peter
    Svaldi, Jennifer
    Stanchi, Karin Melanie Cabanillas
    PALLIATIVE & SUPPORTIVE CARE, 2024, 22 (06) : 1693 - 1700
  • [37] Autologous Stem-Cell Transplantation As First-Line Therapy in Peripheral T-Cell Lymphomas: Results of a Prospective Multicenter Study
    Reimer, Peter
    Ruediger, Thomas
    Geissinger, Eva
    Weissinger, Florian
    Nerl, Christoph
    Schmitz, Norbert
    Engert, Andreas
    Einsele, Hermann
    Mueller-Hermelink, Hans Konrad
    Wilhelm, Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (01) : 106 - 113
  • [38] Physical, Mental, and Social Health of Adult Patients with Sickle Cell Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Mixed-Methods Study
    Dovern, Elisabeth
    Nijland, Sterre J. A. M.
    Muilekom, Maud M. van
    Suijk, Liesbeth M. J.
    Hoogendoorn, Gerianne M.
    Mekelenkamp, Hilda
    Biemond, Bart J.
    Haverman, Lotte
    Nur, Erfan
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (04): : 283.e1 - 283.e9
  • [40] The impact of education on patients' psycho-emotional status during allogeneic hematopoietic stem cell transplantation: a multicenter prospective study by thes Gruppo Italiano Trapianto di Midollo Osseo
    Cioce, Marco
    Borrelli, Ivan
    Cappucciati, Lorella
    Giori, Manuela
    Gobbi, Giorgia
    Lucifora, Roberto
    Mabilia, Patrizia
    Marsullo, Mauro
    Prendin, Chiara
    Russo, Letteria
    Zucca, Maria Silvia
    Zega, Maurizio
    Sica, Simona
    Bacigalupo, Andrea
    De Stefano, Valerio
    Savoia, Vezio
    Celli, Danilo
    Garau, Paola
    Serra, Nicola
    Botti, Stefano
    JOURNAL OF PSYCHOSOCIAL ONCOLOGY, 2023, 41 (06) : 687 - 703